Cyclin-dependent kinase inhibitors - PubMed (original) (raw)
Affiliations
- PMID: 14593718
Review
Cyclin-dependent kinase inhibitors
Peter M Fischer et al. Prog Cell Cycle Res. 2003.
Abstract
Cyclin-dependent kinases are involved in diverse cellular processes that include cell cycle control, apoptosis, neuronal physiology, differentiation, and transcription. Intensive screening and drug design based on CDK/inhibitor co-crystal structures and on SAR studies have led to the identification and characterization of a large variety of chemical inhibitors of CDKs. Although they all act by competing with ATP for binding at the catalytic site of the kinase, their kinase selectivity varies greatly and remains to be studied in most cases. The requirement for CDKs in many physiological processes justifies their evaluation as potential therapeutic targets against a much larger scope of diseases than initially anticipated.
Similar articles
- Structure-guided discovery of cyclin-dependent kinase inhibitors.
Fischmann TO, Hruza A, Duca JS, Ramanathan L, Mayhood T, Windsor WT, Le HV, Guzi TJ, Dwyer MP, Paruch K, Doll RJ, Lees E, Parry D, Seghezzi W, Madison V. Fischmann TO, et al. Biopolymers. 2008 May;89(5):372-9. doi: 10.1002/bip.20868. Biopolymers. 2008. PMID: 17937404 - Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
Pavletich NP. Pavletich NP. J Mol Biol. 1999 Apr 16;287(5):821-8. doi: 10.1006/jmbi.1999.2640. J Mol Biol. 1999. PMID: 10222191 Review. - ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E. Orzáez M, et al. ChemMedChem. 2009 Jan;4(1):19-24. doi: 10.1002/cmdc.200800185. ChemMedChem. 2009. PMID: 19039815 Review. - High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design.
Schulze-Gahmen U, De Bondt HL, Kim SH. Schulze-Gahmen U, et al. J Med Chem. 1996 Nov 8;39(23):4540-6. doi: 10.1021/jm960402a. J Med Chem. 1996. PMID: 8917641 - Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors.
McInnes C, Wang S, Anderson S, O'Boyle J, Jackson W, Kontopidis G, Meades C, Mezna M, Thomas M, Wood G, Lane DP, Fischer PM. McInnes C, et al. Chem Biol. 2004 Apr;11(4):525-34. doi: 10.1016/j.chembiol.2004.03.022. Chem Biol. 2004. PMID: 15123247
Cited by
- Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present).
Abdel-Mohsen HT, Anwar MM, Ahmed NS, Abd El-Karim SS, Abdelwahed SH. Abdel-Mohsen HT, et al. Molecules. 2024 Feb 16;29(4):875. doi: 10.3390/molecules29040875. Molecules. 2024. PMID: 38398626 Free PMC article. Review. - Events Occurring in the Axotomized Facial Nucleus.
Nakajima K, Ishijima T. Nakajima K, et al. Cells. 2022 Jun 29;11(13):2068. doi: 10.3390/cells11132068. Cells. 2022. PMID: 35805151 Free PMC article. Review. - Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma.
Mohammed ER, Elmasry GF. Mohammed ER, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):686-700. doi: 10.1080/14756366.2022.2036985. J Enzyme Inhib Med Chem. 2022. PMID: 35139719 Free PMC article. - CDK4 has the ability to regulate Aurora B and Cenpp expression in mouse keratinocytes.
Lee SH, Rodriguez LRL, Majumdar R, De Marval PLM, Rodriguez-Puebla ML. Lee SH, et al. Oncol Lett. 2021 Oct;22(4):732. doi: 10.3892/ol.2021.12993. Epub 2021 Aug 11. Oncol Lett. 2021. PMID: 34429772 Free PMC article. - A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis.
Barth ND, Subiros-Funosas R, Mendive-Tapia L, Duffin R, Shields MA, Cartwright JA, Henriques ST, Sot J, Goñi FM, Lavilla R, Marwick JA, Vermeren S, Rossi AG, Egeblad M, Dransfield I, Vendrell M. Barth ND, et al. Nat Commun. 2020 Aug 12;11(1):4027. doi: 10.1038/s41467-020-17772-7. Nat Commun. 2020. PMID: 32788676 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous